The current THRD market cap is 159.06M. The company's latest EPS is USD -0.6841 and P/E is -5.16.
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -11.12M | -19M | -37.71M | -43.95M |
Net Income | -12.81M | -29.61M | -35.16M | -30.82M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 8.43M | 129.16M | 298.68M | 277.71M |
Total Liabilities | 8.09M | 5.69M | 9.61M | 8.63M |
Total Equity | -18.36M | -46.71M | 289.07M | 269.09M |
Market Cap | 159.06M |
Price to Earnings Ratio | -5.16 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.59 |
Price to Book Ratio | 0.59 |
Dividend Yield | - |
Shares Outstanding | 45.06M |
Average Volume (1 week) | 360.3k |
Average Volume (1 Month) | 357.14k |
52 Week Change | -60.86% |
52 Week High | 16.94 |
52 Week Low | 3.18 |
Spread (Intraday) | 0.25 (6.89%) |
Company Name | Third Harmonic Bio Inc |
Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
Website | https://www.thirdharmonicbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions